These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1453077)

  • 1. [Clinical study on demyelinating diseases].
    Nishitani H
    Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1539-45. PubMed ID: 1453077
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical grand rounds. Multiple sclerosis.
    J Tenn Med Assoc; 1984 Feb; 77(2):92-7. PubMed ID: 6727338
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
    Siva A; Saip S; Altintas A; Jacob A; Keegan BM; Kantarci OH
    Mult Scler; 2009 Aug; 15(8):918-27. PubMed ID: 19667020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria.
    Nielsen JM; Korteweg T; Barkhof F; Uitdehaag BM; Polman CH
    Ann Neurol; 2005 Nov; 58(5):781-3. PubMed ID: 16240352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome.
    Ruet A; Deloire MS; Ouallet JC; Molinier S; Brochet B
    Mult Scler; 2011 Mar; 17(3):312-8. PubMed ID: 21071465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis--Susan's shadow.
    Maes M; Ross PJ
    Radiol Technol; 2000; 71(3):290-2. PubMed ID: 10665052
    [No Abstract]   [Full Text] [Related]  

  • 7. The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord.
    Miller DH; Ormerod IE; Rudge P; Kendall BE; Moseley IF; McDonald WI
    Ann Neurol; 1989 Nov; 26(5):635-9. PubMed ID: 2817838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Features of the demyelinating process in patients with multiple sclerosis].
    Stoliarov ID; Ogurtsov RP; Petrov AM; Rudas MS; Votintseva MV; Ivashkova EV; Bisaga GN; Trofimova TN; Brodskaia ZL; Skvortsova TIu
    Fiziol Cheloveka; 1999; 25(5):31-4. PubMed ID: 10570879
    [No Abstract]   [Full Text] [Related]  

  • 9. Overdiagnosis of multiple sclerosis by magnetic resonance imaging.
    Goodin DS; Frohman EM
    Ann Neurol; 2006 Mar; 59(3):575-6; author reply 576. PubMed ID: 16489616
    [No Abstract]   [Full Text] [Related]  

  • 10. Spinal cord involvement in multiple sclerosis: a correlative MRI and high-resolution HLA-DRB1 genotyping study.
    Qiu W; Raven S; James I; Luo Y; Wu J; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Neurol Sci; 2011 Jan; 300(1-2):114-9. PubMed ID: 20884011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
    Falcone M; Scalise A; Minisci C; Romito D; Cancelli I; Gigli GL
    Neurol Sci; 2006 Apr; 27(1):58-62. PubMed ID: 16688601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Zacchi T; Nasuelli D; Ukmar M; Furlan C; Pozzi-Mucelli R; Tommasi MA; Locatelli L; Ulivi S; Bratina A; Bosco A; Grop A; Cazzato G; Zorzon M
    J Neurol; 2003 Sep; 250(9):1099-106. PubMed ID: 14504973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
    Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
    J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event.
    Gout O; Bouchareine A; Moulignier A; Deschamps R; Papeix C; Gorochov G; Héran F; Bastuji-Garin S
    Mult Scler; 2011 Feb; 17(2):164-72. PubMed ID: 20965960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demyelinating lesions as an incidental finding in magnetic resonance imaging of the brain--what shall I tell the patient].
    Airas L
    Duodecim; 2009; 125(11):1201-7. PubMed ID: 19579581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of visual evoked potentials and magnetic resonance imaging in multiple sclerosis].
    Miletto G; Merlihot JM; Nezri M; Stanoyevitch JF; Pernet-Rambaud C; Houis B
    J Fr Ophtalmol; 1988; 11(1):67-73. PubMed ID: 3385127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trauma and multiple sclerosis: medicolegal implications.
    Weintraub MI
    Dev Med Child Neurol; 1988 Jun; 30(3):407-8. PubMed ID: 3402682
    [No Abstract]   [Full Text] [Related]  

  • 18. [HLA-DRW antigens and multiple sclerosis].
    De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging and degree of disability in multiple sclerosis.
    Kiel MK; Greenspun B; Grossman RI
    Arch Phys Med Rehabil; 1988 Jan; 69(1):11-3. PubMed ID: 3337635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple sclerosis and psoriasis].
    Cendrowski W
    Wiad Lek; 1989 May; 42(9):575-8. PubMed ID: 2629326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.